Literature DB >> 1963784

Human fibroblasts release low amounts of reactive oxygen species in response to the potent phagocyte stimulants, serum-treated zymosan, N-formyl-methionyl-leucyl-phenylalanine, leukotriene B4 or 12-O-tetradecanoylphorbol 13-acetate.

B Meier1, H H Radeke, S Selle, G G Habermehl, K Resch, H Sies.   

Abstract

Cell lines of human fibroblasts from primary cultures released reactive oxygen species, and displayed an increase in low-level chemiluminescence when stimulated with serum-treated zymosan, N-formyl-methionyl-leucyl-phenylalanine, leukotriene B4, or 12-O-tetradecanoylphorbol 13-acetate, all of which are known stimulants of respiratory burst in phagocytic cells. Non-serum-treated zymosan, interleukin-6, interleukin-2, interferon-gamma or complement factor C3b were ineffective. The primary radical species produced was O theta.2. Radical formation was continuous for up to 4 h, and it did not occur as an oxidative burst. The low level chemiluminescence probably arose from the excitation of carbonyl groups, since it remained unchanged in the presence of azide and 1,4-diazabicyclo[2.2.2]octane. While the release of reactive oxygen species in phagocytes has a function in defense mechanisms, the sustained production of such species in tissue cells may have a role in signaling mechanisms. The amounts of reactive oxygen species released by the fibroblasts upon stimulation with the stimulants mentioned above were low in comparison with the known stimulatory effects of cytokines [Meier et al. (1989) Biochem. J. 263, 539-545].

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963784     DOI: 10.1515/bchm3.1990.371.2.1021

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  12 in total

Review 1.  Reactive oxygen intermediates involved in cellular regulation.

Authors:  B Meier
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

Review 2.  Superoxide generation of phagocytes and nonphagocytic cells.

Authors:  B Meier
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

3.  CD18/ICAM-1-dependent oxidative NF-kappaB activation leading to nitric oxide production in rat Kupffer cells cocultured with syngeneic hepatoma cells.

Authors:  I Kurose; H Saito; S Miura; H Ebinuma; H Higuchi; N Watanabe; S Zeki; T Nakamura; M Takaishi; H Ishii
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

4.  Dysregulation of plasma amino acid levels in HIV-infection and cancer and its relevance for the immune system.

Authors:  W Dröge; H P Eck; H Gmünder; S Mihm
Journal:  Amino Acids       Date:  1991-06       Impact factor: 3.520

Review 5.  Requirement for prooxidant and antioxidant states in T cell mediated immune responses.--Relevance for the pathogenetic mechanisms of AIDS?

Authors:  W Dröge; H P Eck; H Gmünder; S Mihm
Journal:  Klin Wochenschr       Date:  1991-12-15

6.  Antioxidants selectively suppress activation of NF-kappa B by human T-cell leukemia virus type I Tax protein.

Authors:  R Schreck; R Grassmann; B Fleckenstein; P A Baeuerle
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

7.  The biodegradability of electrospun Dextran/PLGA scaffold in a fibroblast/macrophage co-culture.

Authors:  Hui Pan; Hongliang Jiang; Weiliam Chen
Journal:  Biomaterials       Date:  2008-01-14       Impact factor: 12.479

8.  The cytochrome b-558 molecules involved in the fibroblast and polymorphonuclear leucocyte superoxide-generating NADPH oxidase systems are structurally and genetically distinct.

Authors:  B Meier; A J Jesaitis; A Emmendörffer; J Roesler; M T Quinn
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

9.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.

Authors:  R Schreck; P Rieber; P A Baeuerle
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

10.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.

Authors:  R Schreck; B Meier; D N Männel; W Dröge; P A Baeuerle
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.